Frontiers in Medicine | Regulatory Science

Opinion

Published on 11 Jan 2024

Policy options and practical recommendations for determining priorities in public health research agendas in peripheral countries: insights from a collaborative work initiative in Argentina during the COVID-19 pandemic

in Regulatory Science

Natalia Brenda Fernández
María Georgina Herrera
Matías Blaustein
María Florencia Pignataro

Frontiers in Medicine

doi 10.3389/fmed.2023.1334194

1,496 views

Perspective

Published on 11 Jan 2024

Opportunities and challenges of traditional Chinese medicine doctors in the era of artificial intelligence

in Regulatory Science

Wenyu Li
Xiaolei Ge
Shuai Liu
Lili Xu
Xu Zhai
Linyong Yu

Frontiers in Medicine

doi 10.3389/fmed.2023.1336175

12,598 views
25 citations

Original Research

Published on 11 Jan 2024

Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products

in Regulatory Science

Francisco D. Rodríguez-Gómez
Dominique Monferrer
Oriol Penon
Pilar Rivera-Gil

Frontiers in Medicine

doi 10.3389/fmed.2023.1308047

3,236 views
5 citations

Original Research

Published on 10 Jan 2024

Characteristics of retracted research papers before and during the COVID-19 pandemic

in Regulatory Science

Yuki Furuse

Frontiers in Medicine

doi 10.3389/fmed.2023.1288014

4,045 views
7 citations

Opinion

Published on 09 Jan 2024

Case reports as early safety signals: learning from the COVID-19 vaccination campaign

in Regulatory Science

Michel Goldman
Rebecca E. Chandler

Frontiers in Medicine

doi 10.3389/fmed.2023.1348376

1,522 views
2 citations

Technology and Code

Published on 08 Jan 2024

Will it run?—A proof of concept for smoke testing decentralized data analytics experiments

in Regulatory Science

Sascha Welten
Sven Weber
Adrian Holt
Oya Beyan
Stefan Decker

Frontiers in Medicine

doi 10.3389/fmed.2023.1305415

2,381 views
2 citations

Review

Published on 08 Jan 2024

The ménage à trois of healthcare: the actors in after-AI era under patient consent

in Regulatory Science

Riccardo Saccà
Rachele Turrini
Francesco Ausania
Stefania Turrina
Domenico De Leo

Frontiers in Medicine

doi 10.3389/fmed.2023.1329087

2,803 views
5 citations

Mini Review

Published on 08 Jan 2024

AI and professional liability assessment in healthcare. A revolution in legal medicine?

in Regulatory Science

Claudio Terranova
Clara Cestonaro
Ludovico Fava
Alessandro Cinquetti

Frontiers in Medicine

doi 10.3389/fmed.2023.1337335

16,148 views
44 citations

Systematic Review

Published on 08 Jan 2024

The influence of “industry policy” and “financial institution” configuration effect on innovation performance of China’s biomedical industry-based on necessary condition analysis and qualitative comparative analysis

in Regulatory Science

Yaqiong Zhang

Frontiers in Medicine

doi 10.3389/fmed.2023.1297495

3,304 views
4 citations

Original Research

Published on 05 Jan 2024

Stable closure of acute and chronic wounds and pressure ulcers and control of draining fistulas from osteomyelitis in persons with spinal cord injuries: non-interventional study of MPPT passive immunotherapy delivered via telemedicine in community care

in Regulatory Science

Jeanette Sams-Dodd
Maurizio Belci
Surendra Bandi
Damian Smith
Frank Sams-Dodd

Frontiers in Medicine

doi 10.3389/fmed.2023.1279100

10,962 views
5 citations

Correction

Published on 05 Jan 2024

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

in Regulatory Science

Hassan Alwafi
Ian C. K. Wong
Abdallah Y. Naser
Amitava Banerjee
Pajaree Mongkhon
Cate Whittlesea
Alaa Alsharif
Li Wei

Frontiers in Medicine

doi 10.3389/fmed.2023.1337712

1,292 views

Original Research

Published on 03 Jan 2024

Transforming medical equipment management in digital public health: a decision-making model for medical equipment replacement

in Regulatory Science

Luying Huang
Wenqian Lv
Qingming Huang
Haikang Zhang
Siyuan Jin
Tong Chen
Bing Shen

Frontiers in Medicine

doi 10.3389/fmed.2023.1239795

5,005 views
5 citations

Brief Research Report

Published on 06 Dec 2023

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic

in Regulatory Science

María Lorena Bacigalupo
María Florencia Pignataro
Carolinne Thays Scopel
Sergiy Kondratyuk
Othoman Mellouk
Gabriela Costa Chaves

Frontiers in Medicine

doi 10.3389/fmed.2023.1287542

6,495 views
4 citations

Original Research

Published on 30 Nov 2023

Quality and quantity of data used by Health Canada in approving new drugs

in Regulatory Science

Joel Lexchin

Frontiers in Medicine

doi 10.3389/fmed.2023.1299239

3,454 views
10 citations

Review

Published on 27 Nov 2023

Defining medical liability when artificial intelligence is applied on diagnostic algorithms: a systematic review

in Regulatory Science

Clara Cestonaro
Arianna Delicati
Beatrice Marcante
Luciana Caenazzo
Pamela Tozzo

Frontiers in Medicine

doi 10.3389/fmed.2023.1305756

31,877 views
111 citations

Original Research

Published on 16 Nov 2023

Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study

in Regulatory Science

María Lucila Gonzalez Donna
María Luisa Cabañas León
Cinthia Gauna Colas
Alicia Pomata Gunsett
Silvia Ferreira Maniero
David Olivares Osuna
Ezequiel Klimovsky
Lucas Coradini
Diego Enrico
Matías Chacón

Frontiers in Medicine

doi 10.3389/fmed.2023.1266246

3,561 views
2 citations

Opinion

Published on 09 Nov 2023

What about Health Education? Hegemony, paradigms in tension and alternatives

in Regulatory Science

Matías Blaustein
Fernando Miguel Garelli

Frontiers in Medicine

doi 10.3389/fmed.2023.1289865

2,147 views
1 citation

Original Research

Published on 08 Nov 2023

Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

in Regulatory Science

Prisha Patel
Judith C. Macdonald
Jayanthi Boobalan
Matthew Marsden
Ruben Rizzi
Marianne Zenon
Jinma Ren
Haitao Chu
Joseph C. Cappelleri
Satrajit Roychoudhury

Frontiers in Medicine

doi 10.3389/fmed.2023.1275817

11,207 views
8 citations

Hypothesis and Theory

Published on 30 Oct 2023

A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply

in Regulatory Science

Gergely Németh
Mánuel László Mágó
Zoltán Kaló
Judit Lám
Tamás Balogh
Valentin Brodszky

Frontiers in Medicine

doi 10.3389/fmed.2023.1282698

4,865 views
6 citations

Policy and Practice Reviews

Published on 30 Oct 2023

Real-world evidence for regulatory decision-making: updated guidance from around the world

in Regulatory Science

Leah Burns
Nadege Le Roux
Robert Kalesnik-Orszulak
Jennifer Christian
Jennifer Dudinak
Frank Rockhold
Sean Khozin
John O’Donnell

Frontiers in Medicine

doi 10.3389/fmed.2023.1236462

18,185 views
26 citations

Perspective

Published on 27 Oct 2023

The philosophy of pharmaceutical regulation—Paternalism or freedom of choice?

in Regulatory Science

Jörg Mahlich
Sybille Riou
Matthieu Verry

Frontiers in Medicine

doi 10.3389/fmed.2023.1264021

2,919 views

Policy and Practice Reviews

Published on 27 Oct 2023

A study on the normative path of ethics review in China: based on the perspective of Panopticism

in Regulatory Science

Leqian Wu
Xiangjin Kong

Frontiers in Medicine

doi 10.3389/fmed.2023.1268046

2,380 views
3 citations

Original Research

Published on 23 Oct 2023

Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities

in Regulatory Science

Lorraine Danks
Boitumelo Semete-Makokotlela
Kennedy Otwombe
Yashmika Parag
Stuart Walker
Sam Salek

Frontiers in Medicine

doi 10.3389/fmed.2023.1265058

5,055 views
7 citations

Original Research

Published on 12 Oct 2023

Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories

in Regulatory Science

Ruitai Fan
Yufei Zheng
Runze Zhou
Narasimha M. Beeraka
Olga A. Sukocheva
Ruiwen Zhao
Shijie Li
Xiang Zhao
Chunying Liu
Song He

Frontiers in Medicine

doi 10.3389/fmed.2023.1203346

5,573 views
5 citations

504 articles

articles

Policy options and practical recommendations for determining priorities in public health research agendas in peripheral countries: insights from a collaborative work initiative in Argentina during the COVID-19 pandemic

Opportunities and challenges of traditional Chinese medicine doctors in the era of artificial intelligence

Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products

Characteristics of retracted research papers before and during the COVID-19 pandemic

Case reports as early safety signals: learning from the COVID-19 vaccination campaign

Will it run?—A proof of concept for smoke testing decentralized data analytics experiments

The ménage à trois of healthcare: the actors in after-AI era under patient consent

AI and professional liability assessment in healthcare. A revolution in legal medicine?

The influence of “industry policy” and “financial institution” configuration effect on innovation performance of China’s biomedical industry-based on necessary condition analysis and qualitative comparative analysis

Stable closure of acute and chronic wounds and pressure ulcers and control of draining fistulas from osteomyelitis in persons with spinal cord injuries: non-interventional study of MPPT passive immunotherapy delivered via telemedicine in community care

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

Transforming medical equipment management in digital public health: a decision-making model for medical equipment replacement

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic

Quality and quantity of data used by Health Canada in approving new drugs

Defining medical liability when artificial intelligence is applied on diagnostic algorithms: a systematic review

Breaking the unvirtuous cycle: barriers and opportunities for research and development in Paraguay. A case study

What about Health Education? Hegemony, paradigms in tension and alternatives

Regulatory agilities impacting review timelines for Pfizer/BioNTech’s BNT162b2 mRNA COVID-19 vaccine: a retrospective study

A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply

Real-world evidence for regulatory decision-making: updated guidance from around the world

The philosophy of pharmaceutical regulation—Paternalism or freedom of choice?

A study on the normative path of ethics review in China: based on the perspective of Panopticism

Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities

Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories